Susan Shanley

6.4k citations

34 papers · 2.4k indexed · 1 hit paper · h-index 18

Reproductive Medicine top 1%
Oncology top 2%
Genetics top 2%
- BRCA gene mutations in cancer 15
- Genetic and rare skin diseases. 4
Dermatology top 2%
- Cancer and Skin Lesions 6
Oral Surgery top 2%
Molecular Biology
- Hedgehog Signaling Pathway Studies 9
- CRISPR and Genetic Engineering 4
- DNA Repair Mechanisms 3
Pathology and Forensic Medicine
- Genetic factors in colorectal cancer 7
Cancer Research
- Cancer Genomics and Diagnostics 7

Co-authors: Rosalind A. Eeles Georgia Chenevix‐Trench Carol Wicking Andrew Tutt Roger A’Hern Audrey Ardern‐Jones Jan Lubiński Jacques De Grève
Cited by: Reproductive Medicine Oncology Genetics
Journals: Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Human Molecular Genetics (1 paper)
Partner nations: United Kingdom Australia United States

In The Last Decade

Susan Shanley

34 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Susan Shanley

Since Specialization

Citations

This map shows the geographic impact of Susan Shanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Shanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Shanley more than expected).

Fields of papers citing papers by Susan Shanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Shanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Shanley. The network helps show where Susan Shanley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan Shanley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan Shanley Line = papers co-authored together Susan Shanley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers Asia-Pacific Journal of Clinical Oncology ·Lyon Mascarenhas,Susan Shanley,Gillian Mitchell,Amanda B. Spurdle,Finlay Macrae,Nicholas Pachter,Daniel D. Buchanan,Robyn L. Ward,Stephen B. Fox,Elaine Duxbury,Rebecca Driessen,Alex Boussioutas	2018	9
2	Diagnosis and Management of Hereditary Basal Cell Skin Cancer Recent results in cancer research ·Susan Shanley,Christopher McCormack	2016	3
3	BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years British Journal of Cancer ·(unknown),Lindsay B. Robertson,Helen Hanson,S. Seal,Margaret Warren-Perry,Deborah Hughes,Imran Howell,Clare Turnbull,Richard S. Houlston,Susan Shanley,Stephen A. Butler,D. Gareth Evans,Gill Ross,Diana Eccles,Andrew Tutt,Nazneen Rahman	2012	79
4	Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests Hereditary Cancer in Clinical Practice ·Marielle Nobbenhuis,Elizabeth Bancroft,Eleanor Moskovic,Fiona Lennard,Paul D.P. Pharoah,Ian Jacobs,Ann Ward,Desmond PJ Barton,Thomas Ind,John H. Shepherd,Jane Bridges,Martin Gore,Chris Haracopos,Susan Shanley,Audrey Ardern‐Jones,Sarah Thomas,Rosalind A. Eeles	2011	5
5	Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London Familial Cancer ·Kelly Kohut,Lucia D’Mello,Elizabeth Bancroft,Sarah Thomas,Mary‐Anne Young,Kathryn Myhill,Susan Shanley,Brian H. J. Briggs,Michelle G. Newman,Ifthikhar M. Saraf,Penny Cox,Sarah Scambler,Lyndon Wagman,Michael T. Wyndham,Rosalind A. Eeles,Michelle Ferris	2011	7
6	Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Intervalbreakdown → Journal of Clinical Oncology ·Peter C.C. Fong,Timothy A. Yap,David S. Boss,Craig P. Carden,Marja Mergui‐Roelvink,Charlie Gourley,Jacques De Grève,Jan Lubiński,Susan Shanley,Christina Messiou,Roger A’Hern,Andrew Tutt,Alan Ashworth,John Stone,James Carmichael,Jan H.M. Schellens,Johann S. de Bono,Stan B. Kaye	2010	745
7	The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers—implications for oncogenetics practice Journal of Medical Genetics ·Elizabeth Bancroft,Imogen Locke,Audrey Ardern‐Jones,Lucia D’Mello,Katharine M. McReynolds,Fiona Lennard,Yolanda Barbáchano,Julian Barwell,Lyndon Walker,Geraldine M. Mitchell,Huw Dorkins,C. Cummings,J. Paterson,Z. Kote-Jarai,Anita Mitra,Sameer Jhavar,Susan N. Thomas,Richard S. Houlston,Susan Shanley,Rosalind A. Eeles	2010	11
8	BRCA1andBRCA2heterozygosity in embryonic stem cells reduces radiation-induced Rad51 focus formation but is not associated with radiosensitivity International Journal of Radiation Biology ·George Sioftanos,M. Ismail,Lisa Föhse,Susan Shanley,Mulugeta Worku,Susan Short	2010	6
9	Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis Clinical Genetics ·DL Smit,Arjen R. Mensenkamp,Sadhanna Badeloe,MH Breuning,MEH Simon,KY Van Spaendonck,C. M. Aalfs,JG Post,Susan Shanley,IPC Krapels,L. H. Hoefsloot,RJA Van Moorselaar,TM Starink,J-P Bayley,Josef Frank,Maurice A. M. Van Steensel,FH Menko	2010	127
10	Unusual presentation of Lynch Syndrome Hereditary Cancer in Clinical Practice ·Veronica Yu,Marco Novelli,Stewart J. Payne,Sam Fisher,Rebecca A. Barnetson,Ian M. Frayling,Ann Barrett,David Goudie,Audrey Ardern‐Jones,Rosalind A. Eeles,Susan Shanley	2009	13
11	Breast cancer immunohistochemistry can be useful in triage of some HNPCC families Familial Cancer ·Susan Shanley,CHAK-HEI FUNG,J. Milliken,James F. Leary,Rebecca A. Barnetson,Mark A. Schnitzler,Judy Kirk	2009	19
12	Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics Journal of Medical Genetics ·Antonis C. Antoniou,Rachel Hardy,Lyndon Walker,D. Gareth Evans,A Shenton,Rosalind A. Eeles,Susan Shanley,Gabriella Pichert,Louise Izatt,Stephen Rose,Gillian Douglas,Diana Eccles,Patrick J. Morrison,Jessica L. Scott,Ron Zimmern,Douglas F. Easton,Paul D.P. Pharoah	2008	137
13	Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines Familial Cancer ·Julia Hall,Susan W. Gray,Roger A’Hern,Susan Shanley,Maggie Watson,Kathryn M. Kash,Robert T. Croyle,Rosalind A. Eeles	2008	9
14	Delivery of cancer genetics services: The Royal Marsden telephone clinic model Familial Cancer ·Susan Shanley,Kathryn Myhill,Rebecca Doherty,Audrey Ardern‐Jones,S. Hall,Cheryl Vince,Sarah Thomas,Peter J. Aspinall,Rosalind A. Eeles	2007	8
15	Accurate Prediction of BRCA1 and BRCA2 Heterozygous Genotype Using Expression Profiling after Induced DNA Damage Clinical Cancer Research ·Zsofia Kote‐Jarai,Lucy Matthews,Ana Osório,Susan Shanley,Ian Giddings,François Moreews,Imogen Locke,D. Gareth Evans,Diana Eccles,Richard D. Williams,Mark Girolami,Colin Campbell,Rosalind A. Eeles	2006	29
16	Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers British Journal of Cancer ·Zsofia Kote‐Jarai,Asher Salmon,T Mengitsu,Michelle Copeland,Audrey Ardern‐Jones,Imogen Locke,Susan Shanley,Brenda Summersgill,Yong‐Jie Lu,Janet Shipley,Rosalind A. Eeles	2005	28
17	The spectrum ofpatched mutations in a collection of Australian basal cell carcinomas Human Mutation ·Timothy Evans,Waranya Boonchai,Susan Shanley,Ian Smyth,Susan A Gillies,Kylie Georgas,Brandon J. Wainwright,Georgia Chenevix‐Trench,Carol Wicking	2000	20
18	Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma Carcinogenesis ·Susan Shanley,G. Chenevix,Jane M. Palmer,Nicholas K. Hayward	1995	22
19	Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals American Journal of Medical Genetics ·Susan Shanley,John W. Ratcliffe,Athel Hockey,Eric Haan,Christine Oley,David Ravine,Nicholas G. Martin,Carol Wicking,Georgia Chenevix‐Trench	1994	250
20	Excessive Follicular Recruitment and Growth in Mothers of Spontaneous Dizygotic Twins Acta geneticae medicae et gemellologiae twin research ·Nicholas G. Martin,Susan Shanley,Katie Butt,John R. Osborne,Greg D. O'Brien	1991	37

About Susan Shanley

Susan Shanley is a scholar working on Genetics, Dermatology and Cancer Research, having authored 34 papers that have together received 2.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (15 papers), Hedgehog Signaling Pathway Studies (9 papers), Genetic factors in colorectal cancer (7 papers), Cancer Genomics and Diagnostics (7 papers), Cancer and Skin Lesions (6 papers), Genetic and rare skin diseases. (4 papers), CRISPR and Genetic Engineering (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Reproductive Medicine (561 citations), Oncology (1.1k citations) and Genetics (967 citations). Susan Shanley has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Rosalind A. Eeles, Georgia Chenevix‐Trench, Carol Wicking, Andrew Tutt, Roger A’Hern, Audrey Ardern‐Jones, Jan Lubiński, Jacques De Grève, Alan Ashworth and Charlie Gourley. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact